Agency for Science, Technology and Research

Agency for Science, Technology and Research
source
Name	Agency for Science, Technology and Research
Formed	1991
Headquarters	Singapore
Jurisdiction	Republic of Singapore

Contents

Agency for Science, Technology and Research is a statutory board in Singapore responsible for research, innovation, and technology translation. Established to consolidate public research capabilities, it coordinates scientific bodies, technology parks, and translational programs across Singapore, interfacing with institutions such as National University of Singapore, Nanyang Technological University, Duke–NUS Medical School and corporations like Temasek Holdings, DBS Bank, and Singapore Airlines. The agency operates in sectors including biomedical sciences, materials science, engineering, and information technology, partnering with entities such as World Health Organization, European Commission, Japan Science and Technology Agency, and Bill & Melinda Gates Foundation.

History

The agency was created by an act of the Parliament of Singapore in 1991 to centralize research functions formerly distributed among bodies like the Ministry of Trade and Industry (Singapore), National Computer Board, and the Ministry of Health (Singapore). Early collaborations included projects with MIT, Imperial College London, ETH Zurich, and CSIRO that aimed to raise capabilities in biotechnology, nanotechnology, and data sciences. During the 2000s it supported initiatives linked to the Human Genome Project, Human Microbiome Project, and regional programs coordinated with Association of Southeast Asian Nations research networks. In the 2010s the organization expanded translational focus through partnerships with GlaxoSmithKline, Pfizer, Roche, and venture entities such as Sequoia Capital and Temasek Holdings, while responding to public health challenges alongside Centers for Disease Control and Prevention, World Health Organization, and the Ministry of Health (Singapore).

Governance is overseen by a board appointed through authorities resembling those in bodies such as Monetary Authority of Singapore and JTC Corporation, with executive leadership collaborating with university provosts from National University of Singapore and Nanyang Technological University and chief scientists from institutes like A*STAR Graduate Academy. Internal divisions mirror international models from Max Planck Society, Fraunhofer Society, Riken, and CSIRO with research performance monitored against benchmarks from Science (journal), Nature (journal), IEEE, and grant frameworks similar to European Research Council and National Institutes of Health. Advisory committees include representatives from corporations such as Deloitte, McKinsey & Company, PwC, and foundations including Wellcome Trust.

The agency oversees multiple institutes modeled after entities like Broad Institute, Salk Institute, Karolinska Institute, and Cold Spring Harbor Laboratory. Institutes focus on biomedicine, exemplified by collaborations with Duke–NUS Medical School, Yong Loo Lin School of Medicine, and pharmaceutical partners such as Novartis and AstraZeneca; on materials science with links to MIT Materials Research Laboratory and Laboratory for Materials and Structures; and on robotics and AI aligning with Massachusetts Institute of Technology Computer Science and Artificial Intelligence Laboratory, Stanford Artificial Intelligence Laboratory, and OpenAI. Specialized centers coordinate clinical translation with hospitals like Singapore General Hospital, KK Women's and Children's Hospital, and international hospitals such as Massachusetts General Hospital.

Signature programs include translational initiatives comparable to the Horizon 2020 framework, startup accelerators resembling Y Combinator, and workforce development similar to Fulbright Program or Rhodes Scholarship-style fellowships. Major initiatives partner with companies like Google, Microsoft, Amazon Web Services, and Huawei for cloud computing, and with international funders such as Bill & Melinda Gates Foundation and Wellcome Trust for global health projects. Public–private programs echo models used by Innovate UK, SBIR (Small Business Innovation Research), and EUREKA to support spinouts, intellectual property portfolios, and technology transfer to firms like ST Engineering and GSK.

Funding streams combine government allocations from ministries including Ministry of Trade and Industry (Singapore), philanthropic grants from organizations such as Rockefeller Foundation and Gates Foundation, and industry contracts with multinationals like Siemens, BASF, and Toyota. Strategic equity partnerships are managed similarly to practices at Temasek Holdings and GIC (Singapore Sovereign Wealth Fund), while research collaborations use contractual models akin to those of European Research Council grants and bilateral programs with Agence nationale de la recherche and National Science Foundation (United States). Licensing and commercialization follow precedents set by Stanford University Office of Technology Licensing and MIT Technology Licensing Office.

The agency contributed to advances in therapeutics, diagnostics, and materials that have been translated into products and companies comparable to spinouts from Harvard University, Oxford University Innovation, and Cambridge Enterprise. Its work supported regional responses to outbreaks coordinated with World Health Organization and capacity-building projects with ASEAN University Network. Notable outcomes include patented technologies and collaborative publications in journals such as Nature (journal), Science (journal), Cell (journal), and conference proceedings of NeurIPS and ICML. Economic impacts are similar in scope to the influence of institutions like Fraunhofer Society and CSIRO on national innovation systems, contributing to workforce development linked to programs akin to SkillsFuture Singapore and entrepreneurship ecosystems reflected in rankings by Global Innovation Index.

Category:Research institutes in Singapore